XML 25 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY:
3 Months Ended
Jun. 30, 2016
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY:  
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY:
.    EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS’ EQUITY:
 
Earnings (Loss) Per Share
 
A reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share is shown below (in thousands, except per share amounts): 
 
 
For the three months ended
 
 
June 30,
 
 
2017
 
2016
Basic earnings (loss) per share:
 
 
 
 

Net earnings (loss)
 
$
(1,300
)
 
$
3,976

 
 
 
 
 
Basic weighted-average shares outstanding
 
78,672

 
77,471


 
 

 
 

Basic earnings (loss) per share
 
$
(0.02
)
 
$
0.05

 
 
 
 
 
Diluted earnings (loss) per share:
 
 

 
 

Basic weighted-average shares outstanding
 
78,672

 
77,471

Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method
 

 
1,882

Diluted weighted-average shares outstanding
 
78,672

 
79,353


 
 

 
 

Diluted earnings (loss) per share
 
$
(0.02
)
 
$
0.05


 
Due to the net loss incurred by the Company during the quarter ended June 30, 2017, the dilutive effect of options, warrants and restricted stock units covering 2.8 million shares of common stock was excluded from the diluted loss per share calculation since the impact on the calculation was anti-dilutive.
 
Additional options and warrants to purchase shares of common stock and restricted stock units that were outstanding during the periods presented but were not included in the computation of diluted earnings (loss) per share because the effect was anti-dilutive are shown below (in thousands, except per share amounts): 
 
 
For the three months ended
 
 
June 30,
 
 
2017
 
2016
Number of shares outstanding under options, warrants and restricted stock units
 
20

 
709

Range of exercise prices for options
 
$32.85

 
$19.07-$32.85


 
Stockholders’ Equity
 
On August 29, 2011, the board of directors adopted a common stock repurchase program.  That program was subsequently modified and expanded, most recently on July 28, 2016.  Under the modified common stock repurchase program, the Company may purchase up to $400.0 million of its common stock through the period ending June 30, 2018. The Company did not repurchase any shares during the three months ended June 30, 2017.  Through June 30, 2017, the Company had repurchased 16.8 million shares of its stock for $285.7 million, leaving remaining capacity of $114.3 million under the stock repurchase program.
 
Accumulated Other Comprehensive Income
 
Accumulated other comprehensive income accumulated balances of $8.7 million and $8.0 million at June 30, 2017 and March 31, 2017, respectively, reflect accumulated foreign currency translation adjustments.